Back

Myeloperoxidase concentration is associated with endothelial dysfunction and can be decreased by lipoxygenase inhibitor Quercetin in acute phase of STEMI.

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Inflammation and immunity Inflammation and microcirculation ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Yaroslav Lutay

The M.D.Strazhesko Institute of Cardiology, Kyiv (Ukraine)

23 More presentations in this session

Presentation thumbnail
Assistant Professor M. Lipinski (Washington, DC, US)
Abstract
Presentation thumbnail
Doctor D. Pedicino (Rome, IT)
Abstract Slides
Presentation thumbnail
Professor D. Wolf (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Doctor E. Kulikowski (Calgary, CA)
Presentation thumbnail
Doctor F. Jansen (Cologne, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Inflammation and immunity

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Myeloperoxidase inhibition reverses the inflammatory proteomic pattern in heart failure with preserved ejection fraction
1 July 2021
thumbnail
Congress Presentation
Endothelial function improvement associated with the new European Society of Cardiology LDL target levels in STEMI patients
18 March 2022
thumbnail
Congress Presentation
Quercetin reduces residual dysglycemia in postmenopausal women with established coronary artery disease: a randomized double-blind trial.
30 August 2026
thumbnail
Congress Presentation
Cardioprotective effects of the flavonoid quercetin against doxorubicin-Induced cardiotoxicity in H9c2 cardiomyoblasts
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources